Abstract PS-021 Table 1
Potentially inappropriate drugDrug Class Percentage of patients Gender Mean age
Fluoxetine Selective serotonin reuptake inhibitor7/4% (26/350) 69,2% female 30,8% male 77.6 years
Glibenclamide Sulfonylurea 26.5% (26/98) 46.2% female 53.8% male78.5 years
Metoclopramide Prokinetic 78.4% (182/232) 59.3% female 40.7% male77.3 years